Australia markets closed

Castle Biosciences, Inc. (CSTL)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
20.50+0.99 (+5.07%)
As of 02:03PM EDT. Market open.
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Cash flows from operating activities
Net income
-57,466
-57,466
-67,138
-31,292
-10,284
Depreciation & amortisation
12,330
12,330
10,543
3,407
472
Deferred income taxes
-223
-223
-1,877
-8,736
0
Stock-based compensation
51,219
51,219
36,321
21,740
8,309
Change in working capital
-6,630
-6,630
-7
-4,102
9,148
Accounts receivable
-14,930
-14,930
-6,218
-4,631
1,663
Inventory
-3,962
-3,962
-1,680
327
-980
Accounts payable
5,707
5,707
582
-182
169
Other working capital
-19,247
-19,247
-47,287
-22,466
5,114
Other non-cash items
635
635
-18,129
-
823
Net cash provided by operating activities
-5,626
-5,626
-41,655
-18,983
9,865
Cash flows from investing activities
Investments in property, plant and equipment
-13,621
-13,621
-5,632
-3,483
-4,751
Acquisitions, net
0
0
-26,966
0
-
Purchases of investments
-189,075
-189,075
-134,689
0
-
Sales/maturities of investments
186,500
186,500
0
-
-
Other investing activities
-
-
547
-63,184
-
Net cash used for investing activities
-16,183
-16,183
-166,545
-66,657
-4,748
Cash flows from financing activities
Debt repayment
-142
-142
-122
-8
-27,359
Common stock issued
-
-
-
0
330,041
Other financing activities
-5,134
-5,134
-1,688
-1,117
-
Net cash used provided by (used for) financing activities
-2,298
-2,298
1,515
5,421
305,890
Net change in cash
-24,107
-24,107
-206,685
-80,219
311,007
Cash at beginning of period
122,948
122,948
329,633
409,852
98,845
Cash at end of period
98,841
98,841
122,948
329,633
409,852
Free cash flow
Operating cash flow
-5,626
-5,626
-41,655
-18,983
9,865
Capital expenditure
-13,621
-13,621
-5,632
-3,483
-4,751
Free cash flow
-19,247
-19,247
-47,287
-22,466
5,114